Trial of Indomethacin in Chronic Pancreatitis

  • days left to enroll
  • participants needed
  • sponsor
    Mayo Clinic
Updated on 16 May 2022
endoscopic retrograde cholangiopancreatography


The researchers are trying to find a way to slow down the progression of chronic pancreatitis (CP) and investigate the possibility of the long term treatment of this disease.

Condition Chronic Pancreatitis
Treatment placebos, indomethacin
Clinical Study IdentifierNCT04207060
SponsorMayo Clinic
Last Modified on16 May 2022


Yes No Not Sure

Inclusion Criteria

Any gender, age ≥ 18 years and < 60 years
Diagnosed with chronic pancreatitis per American Pancreatic Association guidelines (pancreatic calcifications and/or Cambridge 3-4 changes on CT, MRI, and/or ERCP)
Scheduled for an upper GI endoscopic procedure (EGD or EUS) for clinical or research) indications (not conflicting with current investigation)
Able to provide written informed consent
Serum creatinine within normal laboratory range, as measured within 30 days of the baseline study endoscopy
For females of reproductive potential: willing to use highly effective contraception while taking study medication and for an additional 5 days after completing study medication

Exclusion Criteria

Diagnosed with acute pancreatitis requiring hospitalization within the 6 weeks prior to study enrollment
Habitual use of aspirin or non-steroidal anti-inflammatory medications (NSAIDs), defined as use more than once per week
Any use of aspirin or NSAIDs within 1 week of baseline study endoscopy procedure
Allergy to secretin, indomethacin or NSAIDs
History of known chronic renal insufficiency or cirrhosis
History of coronary artery disease, angina pectoris, myocardial infarction, cerebrovascular accident (stroke), or transient ischemic accident (TIA)
History of peptic ulcer or gastrointestinal bleeding
Found to have active GI ulceration at the time of baseline endoscopy
Hospitalized for acute pancreatitis while participating in this research protocol. Participants who are hospitalized for an episode of acute pancreatitis during study participation will be withdrawn from the study, and considered non-accrued
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note